Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Explore innovative ways to price products for maximum profit. Implement these strategies to boost your revenue and attract customers.
23,980 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Microsoft has fallen this year as AI hopes and cloud momentum wobble. Analysts highlight Azure, AI adoption, and cost...
Investors face a clear choice between two CRM juggernauts. This guide breaks down HubSpot and Salesforce, weighing gr...
A company with a massive market cap and years of losses is making waves in investing circles. This piece breaks down ...
A practical look at a top energy stock evolving at the crossroads of renewables and AI. Learn how to assess the setup...
Oil prices rise and equity futures turn lower as tensions with Iran fresh escalate. Investors brace for higher energy...
Investors are urged to rethink risk in today’s markets: volatility is temporary, but liquidity squeezes and balance-s...
U.S. stocks climbed on Tuesday as inflation cooled more than expected, helping the S&P 500 regain ground. Futures poi...
Three fast-growing tech names are drawing July attention, each amid clear AI-driven catalysts and strong quarterly ga...
Volatility creates noise, but it can also reveal the best buying opportunity months for patient investors. Learn wher...
Pediatrix Medical Group stock tumbled on Thursday after earnings highlighted modest revenue pressures and GAAP vs non...
A respected investment firm recently disclosed a new stake in Portland General Electric, adding a signal to watch for...